Issuer · CIK 0001743881
BBIO — BridgeBio Pharma, Inc.
Recent filings
- Jun 8, 2026·Form 4·Sell$1.1M
BBIO/BridgeBio Pharma, Inc.
Kumar Neil · Chief Executive Officer
Mechanical filing
AI thesis skipped - May 26, 2026·Form 4·Sell$792.9K
BBIO/BridgeBio Pharma, Inc.
Kumar Neil · Chief Executive Officer
Mechanical filing
AI thesis skipped - May 19, 2026·Form 4·Other$2.4M
BBIO/BridgeBio Pharma, Inc.
Kumar Neil · Chief Executive Officer
Mechanical filing
AI thesis skipped - May 19, 2026·Form 4·Other$311.7K
BBIO/BridgeBio Pharma, Inc.
Apuli Maricel · Chief Accounting Officer
Mechanical filing
AI thesis skipped - May 19, 2026·Form 4·Sell$413.5K
BBIO/BridgeBio Pharma, Inc.
Scott Randal W. · director
12conviction - May 11, 2026·Form 4·Sell$931.4K
BBIO/BridgeBio Pharma, Inc.
Kumar Neil · Chief Executive Officer
28conviction